Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cluster Crossover Trial of Conventional vs Incremental Antibiotic Prophylaxis for Arrhythmia Device Infection
2014-000459-10Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- Apr 2014
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cefazolin, vancomycin, cefalexin and clindamycin in Cardiac Device Infection (CIEDI) and arrhythmia (2 arms), sponsored by Population Health Research Institute. Primary endpoint: Hospitalization attributed to device infection. Started Apr 2014; status: completed.
02
Drugs
cefazolinvancomycincefalexinclindamycin
03
Conditions
Cardiac Device Infection (CIEDI)arrhythmia
Beyond the preview
Go deeper on 2014-000459-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000459-10.